Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

BD PHASEAL CLOSED SYSTEM TRANSFER DEVICE

K-Number: K123213 · 2013-01-09

ApplicantBecton, Dickinson & CO
Decision Date2013-01-09
Product CodeONB
Advisory CommitteeHO
DecisionSubstantially Equivalent

Device Summary

BD PHASEAL CLOSED SYSTEM TRANSFER DEVICE is the device name listed in this FDA 510(k) record. The listed applicant is Becton, Dickinson & CO. It received FDA 510(k) clearance on 2013-01-09 under 510(k) number K123213. The device is classified under product code ONB. It was reviewed by the HO advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the BD PHASEAL CLOSED SYSTEM TRANSFER DEVICE?

BD PHASEAL CLOSED SYSTEM TRANSFER DEVICE is a medical device that received FDA 510(k) clearance on 2013-01-09. The listed applicant is Becton, Dickinson & CO. The 510(k) number is K123213.

When did BD PHASEAL CLOSED SYSTEM TRANSFER DEVICE receive FDA 510(k) clearance?

BD PHASEAL CLOSED SYSTEM TRANSFER DEVICE received FDA 510(k) clearance on 2013-01-09, under 510(k) number K123213.

Who is the listed applicant for BD PHASEAL CLOSED SYSTEM TRANSFER DEVICE?

The FDA 510(k) record lists Becton, Dickinson & CO as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for BD PHASEAL CLOSED SYSTEM TRANSFER DEVICE?

The FDA product code for BD PHASEAL CLOSED SYSTEM TRANSFER DEVICE is ONB.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Becton, Dickinson & CO as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K160164BD Veritor System for Rapid Detection of Flu A + B Labratory KitK160161BD Veritor System for Rapid Detection of Flu A + B CLIA waived kitK133140BD VERITOR SYSTEM FOR THE RAPID DETECTION OF RSVK133138BD Veritor™ System Flu A+B AssayK130268BD PROBETEC TRICHOMONAS VAGINALIS (TV) QX AMPLIFIED DNA ASSAYK131301BD FACS SAMPLE PREP ASSISTANT III

View all 190 devices →

Related Devices (Code: ONB)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K251722ProSeal™ Transfer Injector (421120, 421130, 421140)Epic Medical Pte. , Ltd.K253033Chemfort® 28-day 20 mm Vial Adaptor and 13 mm ConvertorSimplivia Healthcare , Ltd.K250059BD PhaSeal™ Optima Connecting Set (C83-O); BD PhaSeal™ Optima Spike Set (C180-O)Becton, Dickinson and CompanyK251411Chemfort Female Luer Lock AdaptorSimplivia Healthcare , Ltd.K251340ProSeal™ Bag Spike with Additive Port (423370ST, 423370)Epic Medical Pte. , Ltd.K243976ZeroClear™ Bag Access (423100)Epic Medical Pte. , Ltd.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑